Abstract
The axillary reverse mapping (ARM) technique has been developed to map and preserve arm lymphatic drainage during axillary lymph node dissection (ALND) and/or sentinel lymph node (SLN) biopsy, thereby minimizing arm lymphedema. However, several problems remain to be resolved in the practical application of this technique. This article presents a review of current knowledge regarding ARM and discusses the practical applicability and relevance of this technique. Identification rates of ARM nodes were insufficient using blue dye. Although this was improved using radioisotopes, radioisotopes alone do not permit visual mapping of ARM lymphatics. Fluorescence imaging may be useful to improve the identification rate of ARM nodes and lymphatics. On the other hand, the ARM nodes may be involved with metastatic foci in patients with extensive axillary lymph node metastases. Moreover, the SLN draining the breast may be the same as the ARM node draining the upper extremity in a minority of patients. These issues represent important drawbacks of the ARM procedure. The success of ARM in reducing lymphedema has not yet been determined. Further studies are needed before this can be accepted as a standard procedure in surgical management of breast cancer.
Similar content being viewed by others
Abbreviations
- ARM:
-
Axillary reverse mapping
- ALND:
-
Axillary lymph node dissection
- SLN:
-
Sentinel lymph node
- H&E:
-
Hematoxylin–eosin
References
Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614
Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31–36
Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745–753
Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482–488
Schijven MP, Vingerhoets AJJM, Rutten HJT, Nieuwenhuijzen GAP, Roumen RMH, van Bussel ME, Voogd AC (2003) Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29:341–350
Ronka R, von Smitten K, Tasmuth T, Leidenius M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28–36
Leidenius M, Leivonen M, Vironen J, von Smitten K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92:23–31
Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. JNCI 98:599–609
Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SGA, Lucci A, Cox CE, Hunt KK, Herndon JE II, Giuliano AE (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13:491–500
Sakorafas GH, Peros G, Cataliotti L, Vlastos G (2006) Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15:153–165
Thompson M, Korourian S, Henry-Tillman R, Adkins L, Mumford S, Westbrook KC, Kimberg VS (2007) Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation. Ann Surg Oncol 14:1890–1895
Nos C, Leiseur B, Clough KB, Lecuru F (2007) Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection. Ann Surg Oncol 14:2490–2496
Nos C, Kaufmann G, Clough KB, Collignon M-A, Zerbib E, Cusumano P, Lecuru F (2008) Combined axillary mapping (ARM) technique for breast cancer patients requiring axillary dissection. Ann Surg Oncol 15:2550–2555
Britton TB, Solanki CK, Pinder SE, Mortimer PS, Peters AM, Purushotham AD (2009) Lymphatic drainage pathways of the breast and the upper limb. Nucl Med Commun 30:427–430
Noguchi M, Miwa K, Michigishi T, Yokoyama K, Nishijima H, Takanaka T, Kawashima H, Nakamura S, Kanno H, Nonomura A (1997) The role of axillary lymph node dissection in breast cancer management. Breast Cancer 4:143–153
Siegel BM, Mayzel KA, Love SM (1990) Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg 125:1144–1147
Schunemann H, Willich N (1997) Lymphedema after breast carcinoma. A study of 5868 cases. Dtsch Med Wochenschr 122:536–541
Boneti C, Korourian S, Bland K, Cox K, Adkins LL, Henry-Tillman RS, Klimberg VS (2008) Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy. J Am Coll Surg 206:1038–1044
Klimberg VS (2008) A new concept toward the prevention of lymphedema: axillary reverse mapping. J Surg Oncol 97:563–564
Sappey MPC (1874) Anatomie, Physiologie, Pathologie des vaisseaux Lymphatiques consideres chez L’homme at les Vertebres. A. Delahaye and E. Lecrosnier, Paris
Turner-Warwick RT (1959) The lymphatics of the breast. Br J Surg 46:574–582
Noguchi M, Inokuchi M, Zen Y (2009) Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy. J Surg Oncol 100:100–105
Suami H, Taylor GI, Pan W-R (2007) The lymphatic territories of the upper limb: anatomical study and clinical implications. Plast Reconstr Surg 119:1813–1822
Suami H, Pan W-R, Taylor GI (2007) Changes in the lymph structure of the upper limb after axillary dissection: radiographic and anatomical study in a human cadaver. Plast Reconstr Surg 120:982–991
Ponzone R, Mininanni P, Cassina E, Sismondi P (2008) Axillary reverse mapping in breast cancer: can we spare what we find? Ann Surg Oncol 15:390–391
Casabona F, Bogliolo S, Ferrero S, Boccardo F, Campisi C (2008) Axillary reverse mapping in breast cancer: a new microsurgical lymphatic-venous procedure in the prevention of arm lymphedema. Ann Surg Oncol 15:3318–3319
Casabona F, Bogliolo S, Valenzano Menada M, Sala P, Villa G, Ferrero S (2009) Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients. Ann Surg Oncol 16:2459–2463
Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, Shivers S, Berman C, Wells K, Rapaport D, Shons A, Horton J, Greenberg H, Nicosia S, Clark R, Cantor A, Reintgen DS (1996) Lymphatic mapping and sentinel node biopsy in the patients with breast cancer. J Am Med Assoc 276:1818–1822
Noguchi M, Motomura K, Imoto S, Miyauchi M, Sato K, Iwata H, Ohta M, Kurosumi M, Tsugawa K (2000) A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society. Breast Cancer Res Treat 63:31–40
Noguchi M (2009) Axillary reverse mapping for preventing lymphedema in the axillary lymph node dissection and/or sentinel lymph node biopsy. Breast Cancer. doi:10.1007/s12282-009-0173-1
Noguchi M, Yokoi M, Nakano Y. Axillary reverse mapping with idocyanine fluorescent imaging in patients with breast cancer. J Surg Oncol (submitted)
Celebioglu F, Perbeck L, Frisell J, Grondal E, Svensson L, Danielsson R (2007) Lymph drainage studied by lymphoscintigraphy in the arms after sentinel node biopsy compared with axillary lymph node dissection following conservative breast cancer surgery. Acta Radiol 48:488–495
Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657–3663
McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5313–5319
Suami H, O’Neill JK, Pan W-R, Taylor GI (2008) Superficial lymphatic system of the upper torso: preliminary radiographic results in human cadavers. Plast Reconstr Surg 121:1231–1239
Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, Weigel B, Bonnefoi K, Kirby K, Morehead C (2001) Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748–752
Campisi C, Eretta C, Pertile D, Rin ED, Campisi C, Maccio A, Campisi M, Accogli S, Bellini C, Boniolo E, Boccardo F (2007) Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery 27:333–338
Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, Fleming GF, Formenti S, Hudis C, Kirshner JJ, Krause DA, Kuske RR, Langer AS, Sledge GW Jr, Whelan TJ, Pfister DG et al (2001) Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539–1569
Noguchi M (2002) Does regional treatment improve the survival in patients with operable breast cancer? Breast Cancer Res Treat 76:269–282
Hiraoka M, Mitsumori M, Shibuya K (2002) Adjuvant radiation therapy following mastectomy for breast cancer. Breast Cancer 9:190–195
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noguchi, M. Axillary reverse mapping for breast cancer. Breast Cancer Res Treat 119, 529–535 (2010). https://doi.org/10.1007/s10549-009-0578-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-009-0578-8